RedShift BioAnalytics Funding: $18M Raised, Series D (2020)
RedShift BioAnalytics is based in Burlington, MA. It has raised $18M in total funding. Latest round: Series D.
RedShift BioAnalytics funding overview
RedShift BioAnalytics is based in Burlington, MA. RedShift BioAnalytics has raised $18M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series D announced in January 2020. The round record for RedShift BioAnalytics runs through 2020; nothing later has been disclosed. Investors on record include Waters Corporation, Technology Venture Partners. 2 distinct backers are named across the disclosed rounds.
RedShift BioAnalytics at a glance
Total raised
$18M
Latest round
Series D
Latest round date
January 2020
Headquarters
Burlington, MA
Notable investors
Waters Corporation, Technology Venture Partners
Frequently asked about RedShift BioAnalytics funding
How much has RedShift BioAnalytics raised?
RedShift BioAnalytics has raised $18M in total disclosed funding across the rounds on record.
Who has invested in RedShift BioAnalytics?
Waters Corporation, Technology Venture Partners are named among the investors backing RedShift BioAnalytics.
What was the latest RedShift BioAnalytics funding round?
The most recent disclosed round is a Series D, announced in January 2020.
Where is RedShift BioAnalytics based?
RedShift BioAnalytics is based in Burlington, MA.
When did RedShift BioAnalytics last raise?
The last disclosed RedShift BioAnalytics round closed in January 2020 at Series D.
RedShift BioAnalytics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Burlington below to benchmark round size and investor mix.
